- Critical care
- Ear, Nose and Throat
- Infectious Diseases
- Injuries and Emergencies
- Mental Health
- Metabolic and Endocrine
- Musculoskeletal Health
- Neuroprogressive and Dementia
- Oral and Dental
- Primary Care
- Regenerative Medicine
- Reproductive Health and Childbirth
Our role is to support the delivery of high quality clinical research in Genetics and manage participant recruitment to time and target, both for Genetics studies which are led from Scotland, and studies led from other nations which Scottish sites are participating in. We provide support in the following areas:
- Managing the study portfolio record
- Monitoring the attainment of recruitment targets
- Providing advice on study design and feasibility
- Troubleshooting issues with poor recruitment
- Identifying potential sites for studies
- Facilitating access to resource to support research, for example through Clinical Research Facility (CRF) Research Nurses.
At the moment we support more than 30 Genetics studies, about a third of which are led from Scotland.
The Genetics Specialty supports the delivery and promotion of clinical research studies in a wide range of areas, including:
- Rare diseases
- Causes and prevention of birth defects
- Common disorders such as familial cancer, and
- Genetic approaches to their treatment and prevention.
There are more than 7000 rare genetic disorders which collectively affect 1 person in 17. When viewed as a group, rare diseases are very common. The national approach made possible by the NIHR Clinical Research Network Portfolio, and supported by the Scottish Genetics Specialty Group means we are able to collect together enough people with a particular condition to make a research project feasible. This leads to more opportunities for people with rare genetic diseases to participate in research, which in turn leads to improved care and the development of new treatments.
Event Review: Huntington’s Disease & other Neurodegenerative Disorders in Scotland: New Research Summits to Climb (28 March) - read the review.
NIHR Musketeers Memorandum
The new NIHR Musketeers Memorandum (MM) website is now live. The Memorandum allows a single lead UK genetics unit to rapidly enable set-up for a rare disease non-CTIMP (Clinical Trial of an Investigational Medicinal Product) project, which can then be delivered across all regional genetics centres.
Here you can find useful information relating to the Memorandum, including:
- Musketeers' Memorandum Agreement
- MM Open studies
- MM Closed studies
- MM Process
- MM Eligibility Checklist 2018
- List of NHS Organisations signed up to MM
- MM AWI Guidance 2018
- MM Schedule 1
- MM Schedule of events exemplar
- MM Statement of activities exemplar
- MM Access Policy.
The 'MM Open Studies' document will be updated at regular intervals. If you would like to notify of any updates for your area please do get in touch on email@example.com. If you would like to view an editable version of the open studies spreadsheet please also get in touch on firstname.lastname@example.org.
Patient, carer and public information
NHS Research Scotland is committed to actively involving patients, those who care for them and the public in all aspects of the research process, including shaping future research activity. Read more
Specialty Lead: Dr Jonathan Berg
Performance Manager: Jacqueline Pearson
- 01382 383882
Administrator: Jillian Strachan
- 01382 383879